Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
World J Gastroenterol ; 28(29): 3934-3945, 2022 Aug 07.
Artigo em Inglês | MEDLINE | ID: mdl-36157549

RESUMO

BACKGROUND: Biliary decompression is well known to greatly decrease the risks of mortality in acute cholangitis (AC). Although early biliary drainage is recommended by the treatment guidelines for AC, the best time for performing this procedure is yet to be established. Furthermore, since the clinical outcomes of patients with severe AC vary dramatically, screening for patients that could benefit the most from early drainage would be more beneficial than the drainage performed based on the severity grade criteria. AIM: To investigate the optimal drainage timing for AC patients with each disease severity grade and organ dysfunction. METHODS: In this retrospective monocenter cohort analysis, we reviewed 1305 patients who were diagnosed with AC according to the Tokyo guidelines 2018 at a Chinese tertiary hospital between July 2016 and December 2020. Demographic characteristics including age and sex, clinical and laboratory characteristics, and imaging findings of each patient were obtained from electronic medical records. We investigated the all-cause in-hospital mortality (IHM), hospital length of stay (LOS), and hospitalization costs associated with the timing of biliary drainage according to the severity grading and different dysfunctioning organs and predictors [age, white blood cell (WBC) count, total bilirubin, albumin, lactate, malignant obstruction, and Charlton comorbidity index (CCI)]. RESULTS: Biliary drainage within 24 or 48 h in Grade III AC patients could dramatically decrease IHM (3.9% vs 9.0%, P = 0.041; 4% vs 9.9%, P = 0.018, respectively), while increasing LOS and hospitalization costs. Multivariate logistic analysis revealed that neurological, respiratory, renal, and cardiovascular dysfunctions, hypoalbuminemia, and malignant obstruction were significantly associated with IHM (odds ratio = 5.32, 2.541, 6.356, 4.021, 5.655, and 7.522; P < 0.001, P = 0.016, P < 0.001, P = 0.012, P < 0.001, and P < 0.001; respectively). Biliary decompression performed within 12 h of admission significantly decreased the IHM in AC patients with neurological dysfunction (0% vs 17.3%, P = 0.041) or with serum lactate > 2 mmol/L (0% vs 5.4%, P = 0.016). In the subgroup of AC patients with renal dysfunction, abnormal WBC count, hyperbilirubinemia, or hypoalbuminemia, early drainage (< 24 h) reduced the IHM (3.6% vs 33.3%, P = 0.004; 1.9% vs 5.8%, P = 0.031; 1.7% vs 5.0%, P = 0.019; 0% vs 27%, P = 0.026; respectively). The IHM was lower in patients with AC combined with hepatic dysfunction, malignant obstruction, or a CCI > 3 who had undergone biliary drainage within 48 h (2.6% vs 20.5%, P = 0.016; 3.0% vs 13.5%, P = 0.006; 3.4% vs 9.6%, P = 0.021; respectively). CONCLUSION: Biliary drainage within 12 h is beneficial for AC patients with neurological or cardiovascular dysfunction, while complete biliary decompression within 24 h of admission is recommended for treating patients with Grade III AC.


Assuntos
Colangite , Hipoalbuminemia , Doença Aguda , Albuminas , Bilirrubina , Colangiopancreatografia Retrógrada Endoscópica/efeitos adversos , Colangite/complicações , Colangite/terapia , Drenagem/métodos , Humanos , Hipoalbuminemia/etiologia , Lactatos , Estudos Retrospectivos
2.
Angiology ; 73(4): 357-364, 2022 04.
Artigo em Inglês | MEDLINE | ID: mdl-34951316

RESUMO

Previous studies reported regional variations in in-hospital acute coronary syndrome (ACS) mortality, but the reasons for that were not clearly defined. We explored whether differences in patient characteristics could explain regional variation. The Improving Care for Cardiovascular Disease in China (CCC)-ACS project is an ongoing national registry and quality improvement project, involving 150 tertiary hospitals from 30 provinces across China. We applied a prediction model that included patient-specific variables to calculate the expected in-hospital mortality. For each province, we reported the observed, expected in-hospital mortality and the risk-adjusted ratio which is based on the observed divided by the expected mortality. From 2014 to 2018, 79 585 ACS patients were enrolled. The average in-hospital mortality was 1.8%. There was a wide variation in the in-hospital mortality among different provinces (0.2-3.9%). Patient characteristics explained part of this variation because of differences in the expected in-hospital mortality (0.7-2.8%). There was a substantial variation in the risk-adjusted ratio among provinces (0.2-3.5), which suggests that the variations in the mortality cannot be completely explained by the differences in patient characteristics. In conclusion, we observed a wide regional variation in mortality for ACS, part of which could be explained by the difference in patient characteristics.


Assuntos
Síndrome Coronariana Aguda , Doenças Cardiovasculares , Síndrome Coronariana Aguda/terapia , China/epidemiologia , Mortalidade Hospitalar , Humanos , Melhoria de Qualidade , Sistema de Registros
3.
Am J Trop Med Hyg ; 106(2): 710-713, 2021 11 29.
Artigo em Inglês | MEDLINE | ID: mdl-34844206

RESUMO

A 20-year-old female resident of Beijing intended to consume the eggs of the parasitic worm, Taenia saginata, for weight loss; however, she apparently inadvertently ingested Taenia solium (pork tapeworm) eggs, which resulted in disseminated cysticercosis. Cysticerci developed in the brain, tongue, muscles, liver, peritoneum, and subcutaneous tissues. She was administered oral albendazole and praziquantel. After four 10-day courses of treatment, most of the cysts disappeared and she recovered. After 3 years, the patient remains in good health.


Assuntos
Anti-Helmínticos/uso terapêutico , Encéfalo/patologia , Cisticercose/patologia , Taenia solium/patogenicidade , Língua/patologia , Albendazol/uso terapêutico , Animais , Encéfalo/diagnóstico por imagem , Encéfalo/parasitologia , Cisticercose/diagnóstico por imagem , Cisticercose/tratamento farmacológico , Cisticercose/parasitologia , Feminino , Humanos , Fígado/diagnóstico por imagem , Fígado/parasitologia , Fígado/patologia , Músculos/diagnóstico por imagem , Músculos/parasitologia , Músculos/patologia , Peritônio/diagnóstico por imagem , Peritônio/parasitologia , Peritônio/patologia , Praziquantel/uso terapêutico , Tela Subcutânea/diagnóstico por imagem , Tela Subcutânea/parasitologia , Tela Subcutânea/patologia , Taenia saginata , Taenia solium/crescimento & desenvolvimento , Língua/diagnóstico por imagem , Língua/parasitologia , Resultado do Tratamento , Redução de Peso , Adulto Jovem , Zigoto/crescimento & desenvolvimento , Zigoto/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...